ES2361950T3 - Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer. - Google Patents

Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer. Download PDF

Info

Publication number
ES2361950T3
ES2361950T3 ES07813073T ES07813073T ES2361950T3 ES 2361950 T3 ES2361950 T3 ES 2361950T3 ES 07813073 T ES07813073 T ES 07813073T ES 07813073 T ES07813073 T ES 07813073T ES 2361950 T3 ES2361950 T3 ES 2361950T3
Authority
ES
Spain
Prior art keywords
myb
antibody
gene
nucleic acid
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07813073T
Other languages
English (en)
Spanish (es)
Inventor
John Chant
Anthony S. Guerrero
Peter Haverty
Cynthia Honchell
Kenneth Jung
Thomas D. Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2361950T3 publication Critical patent/ES2361950T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES07813073T 2006-07-19 2007-07-18 Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer. Active ES2361950T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80779406P 2006-07-19 2006-07-19
US807794P 2006-07-19

Publications (1)

Publication Number Publication Date
ES2361950T3 true ES2361950T3 (es) 2011-06-24

Family

ID=38957597

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07813073T Active ES2361950T3 (es) 2006-07-19 2007-07-18 Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer.

Country Status (8)

Country Link
US (2) US20100028365A1 (https=)
EP (1) EP2041320B1 (https=)
JP (1) JP5297375B2 (https=)
AT (1) ATE502123T1 (https=)
CA (1) CA2658319A1 (https=)
DE (1) DE602007013234D1 (https=)
ES (1) ES2361950T3 (https=)
WO (1) WO2008011482A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110030074A1 (en) * 2007-05-21 2011-02-03 Dana Farber Cancer Institute, Inc. Compositions and methods for cancer gene discovery
WO2012135696A2 (en) * 2011-04-01 2012-10-04 University Of South Alabama Methods and compositions for the diagnosis, classification, and treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047152A2 (en) * 1998-03-20 1999-09-23 Sloan Kettering Institute For Cancer Research Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
US20030049203A1 (en) * 2001-08-31 2003-03-13 Elmaleh David R. Targeted nucleic acid constructs and uses related thereto

Also Published As

Publication number Publication date
JP5297375B2 (ja) 2013-09-25
WO2008011482A3 (en) 2008-04-03
CA2658319A1 (en) 2008-01-24
EP2041320B1 (en) 2011-03-16
WO2008011482A2 (en) 2008-01-24
EP2041320A2 (en) 2009-04-01
DE602007013234D1 (de) 2011-04-28
US20130317082A1 (en) 2013-11-28
US20100028365A1 (en) 2010-02-04
JP2010500869A (ja) 2010-01-14
ATE502123T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
US8945572B2 (en) Methods and compositions for the diagnosis and treatment of cancer
AU2006340769A1 (en) Method for diagnosing, prognosing and treating glioma
IL187343A (en) Preparations and methods for diagnosing and treating the tumor
US20090324595A1 (en) Cancer prognostic diagnostic and treatment methods
JP2010526029A (ja) がんを処置し、診断し、そして検出するためのｆｘｙｄ５調節剤
ES2361950T3 (es) Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer.
ES2372217T3 (es) Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer de pulmón utilizando el gen de pdgfra, kit o kdr como marcador genético.
HK1108924B (en) Cancer prognostic methods